2022 | A Year of Purpose-Led Convergence

These are my top 4 predictions for the Healthcare sector in 2022.

Each contributor to this sector has to finely balance rigour and quality of service with a more agile, rapid response to market dynamics, while positioning against some form of innovation.  

We all know the challenges, and can pinpoint the bottlenecks and backlogs. But we’ve also collectively acknowledged that having to embrace such high-risk stakes over the last 2 years has  unleashed a pioneering spirit, that has not only dismantled boundaries, but illustrated that cross-disciplinary groups with a shared purpose can move mountains – paving the way for a multi-pronged approach to tackling some of Healthcare’s greatest challenges.

And of course, technology remains the critical enabler.

Continue reading “2022 | A Year of Purpose-Led Convergence”

Value-Based Contracting is the New Sustainable | Is the Tech Community Ready?

Value over Costs | Outcomes over Processes  

Sustainability will be key across Healthcare in 2022, and many are backing value-based care as the route to survival, post-pandemic and beyond. This time it’s different – an international movement is driving this. You need to sign up.    

Continue reading “Value-Based Contracting is the New Sustainable | Is the Tech Community Ready?”

How to Support Healthcare’s Rising Star – The CIO

All Hail the CIO!  

More Health and Life Sciences (HLS) leaders now appreciate that ‘digital’ is a living breathing culture that empowers during volatility, uncertainty, and complexity. The CIO has emerged from the pandemic as a hero. As they start to re-evaluate priorities over the next three years and determine their future vision, they’ll need you more than ever.

Continue reading “How to Support Healthcare’s Rising Star – The CIO”

Citizen Scientists in Healthcare | The Bridge to Precision Medicine

Democratisation Accelerates Discovery

True patient-centricity remains an aspiration. We agree that patients still get a raw deal. And we know that despite some effort, the disconnect between how health systems and Pharma view ‘centricity’ versus those living with chronic health remains wide. Patient advocacy groups are under-utilised. Telehealth is being pushed as a catch-all model, and in the wrong context.

Patients have always been ahead of the curve. Many know the value of their data and are comfortable sharing, in what they feel is the right context. Savvy health tech companies – such as HealthUnlocked (Corrona), PatientsLikeMe, and PatientsKnowBest – have successfully harnessed the power of the direct collaboration model, also proving that patients are open to consenting access to Pharma and HCPs to secure anonymised data, for a fee.

Citizen science goes way beyond this.

Continue reading “Citizen Scientists in Healthcare | The Bridge to Precision Medicine”

Smart Healthy Cities | A Welsh Exemplar

Sustaining Our Communities Through Networked Wellbeing Villages

It’s a bold promise to offer personalised, preventive, integrated healthcare & wellbeing within a socially cohesive community. The Welsh regenerative project, Pentre Awel, aims to deliver.  

Unlike projects such as Saudi Arabia’s NEOM City, this is tailored to supporting the local community’s needs- high deprivation, unemployment, an ageing population, and chronic co-morbidity. Geared to be high-tech and high-touch, participatory care, shared facilities, and telemedicine will be standard.

Continue reading “Smart Healthy Cities | A Welsh Exemplar”

(Digital) Psychedelics at the Intersection of Neurotech & AI

Our escalating global mental health crisis needs a compelling response. No longer on the fringes, psychedelic drugs (aka hallucinogens) as a legalised assisted treatment may offer a breakthrough. Governments, HCPs, Biotechs, and VCs think so. AI is driving discovery and new integrated models of care. Digital is following.

Continue reading “(Digital) Psychedelics at the Intersection of Neurotech & AI”

Ethics and AI

With the value of real-time data access so evident during this pandemic, the conversation on AI has become amplified X-fold across healthcare systems, Research, and Pharma (‘Healthcare’). Great news for many among you. But you can make an even deeper contribution by committing to the drive for ethics.

Ethics relates to how, in the absence of any framework, all stakeholders can work to set clear parameters on the safe adoption and integration of AI – to build towards consistency across real-world settings (clinical and in the community), discovery research, and smart city design.

No-one is suggesting that tech solutions have been sold on hype. But since regulators are deemed to not yet have all of the appropriate skills to evaluate good AI, Healthcare is taking ownership, to scrutinise validity and tech impact across the AI life cycle.

Continue reading “Ethics and AI”

Pharma’s High Stakes in DTx and Mental Health | Otsuka’s Mixed Run

Pharma’s Stake in the Ground

Since mental health treatment has until recently received relatively poor coverage, it’s no wonder that the role ‘Big Pharma’ has played has largely gone unnoticed, particularly among the public.

For good reason: a drugs pipeline that has not developed any breakthroughs in decades; a reluctance to commit to R&D investment to understand how psychiatric medications work; a collective portfolio of generic medications to cover a broad spectrum of mental health conditions. Consequently, not only have patients been exposed to a reliance among providers to over-medicate, too many have not had their case management reviewed regularly, leading to poor outcomes.         

But the perfect storm that has rattled across the Pharma sector in recent years has triggered some remarkable mental health interventions that offer alternative pathways. The enabler – digital therapeutics (DTx).

Continue reading “Pharma’s High Stakes in DTx and Mental Health | Otsuka’s Mixed Run”
error: Content is protected !!